Huc-MSCs-derived exosomes attenuate inflammatory pain by regulating microglia pyroptosis and autophagy via the miR-146a-5p/TRAF6 axis

  • J Nanobiotechnology. 2022 Jul 14;20(1):324. doi: 10.1186/s12951-022-01522-6.
Tong Hua   #  1 ,  Mei Yang   #  1 ,  Honghao Song   #  1 ,  Erliang Kong  1 ,  Mengqiu Deng  1 ,  Yongchang Li  1 ,  Jian Li  1 ,  Zhixiao Liu  2 ,  Hailong Fu  3 ,  Yue Wang  4 ,  Hongbin Yuan  5
Affiliations
  • 1. Department of Anesthesiology, Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
  • 2. Research Center of Developmental Biology, Department of Histology and Embryology, College of Basic Medicine, Naval Medical University, Shanghai, 200433, China.
  • 3. Department of Anesthesiology, Changzheng Hospital, Naval Medical University, Shanghai, 200003, China. [email protected].
  • 4. Stem Cell and Regeneration Medicine Institute, Research Center of Translational Medicine, Naval Medical University, Shanghai, 200433, China. [email protected].
  • 5. Department of Anesthesiology, Changzheng Hospital, Naval Medical University, Shanghai, 200003, China. [email protected].
  • # Contributed equally.
PMID: 35836229 DOI: 10.1186/s12951-022-01522-6
Abstract

Background: Chronic inflammatory pain significantly reduces the quality of life and lacks effective interventions. In recent years, human umbilical cord mesenchymal stem cells (huc-MSCs)-derived exosomes have been used to relieve neuropathic pain and Other inflammatory diseases as a promising cell-free therapeutic strategy. However, the therapeutic value of huc-MSCs-derived exosomes in complete Freund's Adjuvant (CFA)-induced inflammatory pain remains to be confirmed. In this study, we investigated the therapeutic effect and related mechanisms of huc-MSCs-derived exosomes in a chronic inflammatory pain model.

Methods: C57BL/6J male mice were used to establish a CFA-induced inflammatory pain model, and huc-MSCs-derived exosomes were intrathecally injected for 4 consecutive days. BV2 microglia cells were stimulated with lipopolysaccharide (LPS) plus adenosine triphosphate (ATP) to investigate the effect of huc-MSCs-derived exosomes on Pyroptosis and Autophagy. Bioinformatic analysis and rescue experiments were used to demonstrate the role of miR-146a-5p/ TRAF6 in regulating Pyroptosis and Autophagy. Western blotting, RT-qPCR, small interfering RNA and Yo-Pro-1 dye staining were performed to investigate the related mechanisms.

Results: Huc-MSCs-derived exosomes alleviated mechanical allodynia and thermal hyperalgesia in CFA-induced inflammatory pain. Furthermore, huc-MSCs-derived exosomes attenuated neuroinflammation by increasing the expression of autophagy-related proteins (LC3-II and Beclin1) and inhibiting the activation of NLRP3 inflammasomes in the spinal cord dorsal horn. In vitro, NLRP3 inflammasome components (NLRP3, caspase1-p20, ASC) and gasdermin D (GSDMD-F, GSDMD-N) were inhibited in BV2 cells pretreated with huc-MSCs-derived exosomes. Western blot and Yo-Pro-1 dye staining demonstrated that 3-MA, an Autophagy inhibitor, weakened the protective effect of huc-MSCs-derived exosomes on BV2 cell Pyroptosis. Importantly, huc-MSCs-derived exosomes transfected with miR-146a-5p mimic promoted Autophagy and inhibited BV2 cell Pyroptosis. TRAF6, as a target gene of miR-146a-5p, was knocked down via small-interfering RNA, which increased Pyroptosis and inhibited Autophagy.

Conclusion: Huc-MSCs-derived exosomes attenuated inflammatory pain via miR-146a-5p/TRAF6, which increased the level of Autophagy and inhibited Pyroptosis.

Keywords
Autophagy; Huc-MSCs-derived exosomes; Inflammatory pain; Microglia; Pyroptosis.
Products
Inhibitors & Agonists
Other Products